Showing 13 to 22 of 22 results
HHS Ends Funding for mRNA Vaccine Development
The U.S. Department of Health and Human Services is ending funding for 22 mRNA vaccine development projects, totaling about $500 million, prioritizing other vaccine platforms and sparking criticism from health experts who cite the technology's effectiveness against severe COVID-19.
HHS Ends Funding for mRNA Vaccine Development
The U.S. Department of Health and Human Services is ending funding for 22 mRNA vaccine development projects, totaling about $500 million, prioritizing other vaccine platforms and sparking criticism from health experts who cite the technology's effectiveness against severe COVID-19.
Progress
56% Bias Score
HHS Cancels $500 Million in mRNA Vaccine Funding
The US Department of Health and Human Services cancelled $500 million in funding for 22 mRNA vaccine projects targeting viruses like bird flu and Covid-19, a decision driven by Health Secretary Robert F Kennedy Jr's skepticism towards mRNA technology, despite expert criticism.
HHS Cancels $500 Million in mRNA Vaccine Funding
The US Department of Health and Human Services cancelled $500 million in funding for 22 mRNA vaccine projects targeting viruses like bird flu and Covid-19, a decision driven by Health Secretary Robert F Kennedy Jr's skepticism towards mRNA technology, despite expert criticism.
Progress
48% Bias Score
Trump Administration's Cancellation of Flu Vaccine Contracts Weakens U.S. Pandemic Preparedness
The Trump administration canceled $766 million in contracts for mRNA flu vaccine development, weakening U.S. pandemic preparedness and potentially leading to reliance on other countries for vaccines in a future pandemic; this decision follows broader cuts to health agencies and research budgets, exa...
Trump Administration's Cancellation of Flu Vaccine Contracts Weakens U.S. Pandemic Preparedness
The Trump administration canceled $766 million in contracts for mRNA flu vaccine development, weakening U.S. pandemic preparedness and potentially leading to reliance on other countries for vaccines in a future pandemic; this decision follows broader cuts to health agencies and research budgets, exa...
Progress
60% Bias Score
NIH Reviews mRNA Vaccine Research Funding Amidst Concerns of Cuts
The NIH is reviewing funding for mRNA vaccine technology research, potentially cutting funding for at least 130 grants, following the termination of 42 grants studying vaccine hesitancy and research on LGBTQ+ and other vulnerable groups, causing concern among researchers.
NIH Reviews mRNA Vaccine Research Funding Amidst Concerns of Cuts
The NIH is reviewing funding for mRNA vaccine technology research, potentially cutting funding for at least 130 grants, following the termination of 42 grants studying vaccine hesitancy and research on LGBTQ+ and other vulnerable groups, causing concern among researchers.
Progress
52% Bias Score
BioNTech Restructures, Shifting Focus to mRNA Cancer Therapies
BioNTech, due to reduced Covid-19 vaccine demand, will cut 250-350 jobs in Marburg and up to 150 in Idar-Oberstein, but add 800-1200 positions elsewhere, focusing on mRNA cancer therapies with a goal of market approval by 2026.
BioNTech Restructures, Shifting Focus to mRNA Cancer Therapies
BioNTech, due to reduced Covid-19 vaccine demand, will cut 250-350 jobs in Marburg and up to 150 in Idar-Oberstein, but add 800-1200 positions elsewhere, focusing on mRNA cancer therapies with a goal of market approval by 2026.
Progress
40% Bias Score
HHS Cancels $500 Million in mRNA Vaccine Contracts
The Department of Health and Human Services canceled 22 mRNA vaccine contracts worth $500 million due to ineffectiveness against upper respiratory infections and mutations, shifting focus to safer, broader vaccine strategies.
HHS Cancels $500 Million in mRNA Vaccine Contracts
The Department of Health and Human Services canceled 22 mRNA vaccine contracts worth $500 million due to ineffectiveness against upper respiratory infections and mutations, shifting focus to safer, broader vaccine strategies.
Progress
64% Bias Score
US Shift Away From mRNA Vaccines Raises Pandemic Preparedness Concerns
The US government's actions, including the cancellation of a $766 million bird flu vaccine contract and new restrictions on COVID-19 mRNA vaccines, raise concerns about the country's pandemic preparedness and future vaccine development. These decisions follow the dismissal of top vaccine officials a...
US Shift Away From mRNA Vaccines Raises Pandemic Preparedness Concerns
The US government's actions, including the cancellation of a $766 million bird flu vaccine contract and new restrictions on COVID-19 mRNA vaccines, raise concerns about the country's pandemic preparedness and future vaccine development. These decisions follow the dismissal of top vaccine officials a...
Progress
60% Bias Score
Trump Administration Blocks Funding for mRNA Vaccine Research
The Trump administration, bowing to anti-vaccine pressure, is blocking funding for mRNA vaccine research, impacting studies on infectious diseases and cancer, and chilling scientific discourse, despite the technology's life-saving potential.
Trump Administration Blocks Funding for mRNA Vaccine Research
The Trump administration, bowing to anti-vaccine pressure, is blocking funding for mRNA vaccine research, impacting studies on infectious diseases and cancer, and chilling scientific discourse, despite the technology's life-saving potential.
Progress
52% Bias Score
Federally Funded Basic Research: Crucial for Pandemic Preparedness
The rapid development of COVID-19 treatments and vaccines, such as remdesivir and mRNA vaccines, resulted from decades of federally funded basic research, primarily conducted by the NIH, which is now threatened by proposed funding cuts.
Federally Funded Basic Research: Crucial for Pandemic Preparedness
The rapid development of COVID-19 treatments and vaccines, such as remdesivir and mRNA vaccines, resulted from decades of federally funded basic research, primarily conducted by the NIH, which is now threatened by proposed funding cuts.
Progress
44% Bias Score
False Claim: EMA Admitted mRNA Vaccines Lack Official Approval
Uncut-News falsely claims the EMA admitted mRNA vaccines are unapproved, citing a document about veterinary vaccines; however, the EMA's position emphasizes the rigorous testing and approval of human mRNA vaccines used in the COVID-19 pandemic.
False Claim: EMA Admitted mRNA Vaccines Lack Official Approval
Uncut-News falsely claims the EMA admitted mRNA vaccines are unapproved, citing a document about veterinary vaccines; however, the EMA's position emphasizes the rigorous testing and approval of human mRNA vaccines used in the COVID-19 pandemic.
Progress
68% Bias Score
Showing 13 to 22 of 22 results